T. Rowe Price Investment Management, Inc. 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-07 2:28 pm Purchase | 2026-07-31 | 13G | DIANTHUS THERAPEUTICS INC DNTH | T. Rowe Price Investment Management, Inc. | 6,632,303 12.100% | 2,743,847 (+70.56%) | Filing |
| 2026-08-07 2:22 pm Purchase | 2026-06-30 | 13G | DIANTHUS THERAPEUTICS INC DNTH | T. Rowe Price Investment Management, Inc. | 3,888,456 7.100% | 3,888,456 (New Position) | Filing |